Aksit, ErcanKucuk, UgurTaylan, GokayCinier, GokselKarabay, Can YucelAkgun, Taylan2024-06-122024-06-1220220167-52731874-1754https://doi.org/10.1016/j.ijcard.2022.01.025https://hdl.handle.net/20.500.14551/18552[Abstract Not Available]en10.1016/j.ijcard.2022.01.025info:eu-repo/semantics/closedAccessAnti-Fibrotic DrugsArrhythmogenic CardiomyopathyCardiac FibrosisRemodelingThe importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasiaLetter3535353Q2WOS:0007843305000122-s2.0-8512630146635051491Q1